Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Julian Aldana"'
Publikováno v:
Metabolites, Vol 10, Iss 6, p 231 (2020)
In recent years, high-throughput lipid profiling has contributed to understand the biological, physiological and pathological roles of lipids in living organisms. Across all kingdoms of life, important cell and systemic processes are mediated by lipi
Externí odkaz:
https://doaj.org/article/57fe34ccf65843d799d78b2d4bb9518f
Autor:
Mónica P Cala, Julian Aldana, Jessica Medina, Julián Sánchez, José Guio, Julien Wist, Roland J W Meesters
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0190958 (2018)
Breast cancer (BC) is a highly heterogeneous disease associated with metabolic reprogramming. The shifts in the metabolome caused by BC still lack data from Latin populations of Hispanic origin. In this pilot study, metabolomic and lipidomic approach
Externí odkaz:
https://doaj.org/article/e79e40645fc546ad94a004be441bd2eb
Autor:
Evangelia Chavdoula, Vollter Anastas, Allesandro La Ferlita, Julian Aldana, Giuseppe Carota, Mariarita Spampinato, Sameer Parashar, Ilaria Cosentini, Burak Soysal, Giovanni Nigita, Michael Freitas, Philip Tsichlis
Publikováno v:
Cancer Research. 83:6038-6038
Our earlier studies had shown that overexpression of the JmjC domain histone demethylase KDM2B renders mouse embryo fibroblasts (MEFs) resistant to oxidative stress due to the role of KDM2B in the regulation of antioxidant mechanisms. Here we present
Autor:
Michael A. Freitas, Long Zhang, Lakmal Jayasinghe, Nicolas Burns, Julian Aldana, Miranda L. Gardner, Michael I. Jordan, Peixuan Guo
Publikováno v:
Biomaterials
Protein post-translational modification (PTM) is crucial to modulate protein interactions and activity in various biological processes. Emerging evidence has revealed PTM patterns participate in the pathology onset and progression of various diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66a59d018de08773eda34a86384d9e7c
https://europepmc.org/articles/PMC8405592/
https://europepmc.org/articles/PMC8405592/
Autor:
Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita, Julian Aldana, Anuvrat Sircar, Michael A. Freitas, Lalit Sehgal, Philip N. Tsichlis
Publikováno v:
Cancer Research. 82:3019-3019
Epigenetic and metabolic alterations in cancer cells are intertwined. The concentration of metabolites can influence the activity of chromatin modifiers, which in turn can act as metabolic sensors that translate changes in cellular metabolism to tran
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 152:234-241
Metabolic biomarkers for breast cancer (BC) prognosis and diagnosis are required, given the increment of BC incidence rates in developing countries and its prevalence in women worldwide. Human urine represents a useful resource of metabolites for bio
Publikováno v:
Metabolites
Metabolites, Vol 10, Iss 231, p 231 (2020)
Metabolites, Vol 10, Iss 231, p 231 (2020)
In recent years, high-throughput lipid profiling has contributed to understand the biological, physiological and pathological roles of lipids in living organisms. Across all kingdoms of life, important cell and systemic processes are mediated by lipi
Autor:
Roland J. W. Meesters, Julián Sánchez, Julian Aldana, Jessica Medina, Julien Wist, José Guio, Mónica P. Cala
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0190958 (2018)
PLoS ONE
PLoS ONE
Breast cancer (BC) is a highly heterogeneous disease associated with metabolic reprogramming. The shifts in the metabolome caused by BC still lack data from Latin populations of Hispanic origin. In this pilot study, metabolomic and lipidomic approach